COAG (Hemab Therapeutics Holdings) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COAG Hemab Therapeutics Holdings Inc COAG
11 GF Score
Price $46.52
! 2 Warning Signs
View Full Analysis

What is Hemab Therapeutics Holdings FCF Margin %?

Hemab Therapeutics Holdings COAG +3.48% 11 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates COAG with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 953 Biotechnology companies, Hemab Therapeutics Holdings ranks worse than 104931.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hemab Therapeutics Holdings's Free Cash Flow for the six months ended in Dec. 2025 was $-61.49 Mil. Hemab Therapeutics Holdings's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Hemab Therapeutics Holdings's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Hemab Therapeutics Holdings's current FCF Yield % is -2.83%.

The historical rank and industry rank for Hemab Therapeutics Holdings's FCF Margin % or its related term are showing as below:


COAG's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -79.91
* Ranked among companies with meaningful FCF Margin % only.

Hemab Therapeutics Holdings FCF Margin % Related Terms

Hemab Therapeutics Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Hemab Therapeutics Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemab Therapeutics Holdings FCF Margin % Chart

Hemab Therapeutics Holdings Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Hemab Therapeutics Holdings Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

COAG vs ZLAB, SLS, IOVA: FCF Margin % Comparison

For the Biotechnology subindustry, Hemab Therapeutics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemab Therapeutics Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemab Therapeutics Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hemab Therapeutics Holdings's FCF Margin % falls into.


COAG
11GF Score
Hemab Therapeutics Holdings Inc COAG
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemab Therapeutics Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hemab Therapeutics Holdings's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-61.491/0
= %

Hemab Therapeutics Holdings's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-61.491/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Hemab Therapeutics Holdings (COAG) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hemab Therapeutics Holdings and its competitors. According to the industry distribution chart, Hemab Therapeutics Holdings ranks #999999 out of 953 companies in the Biotechnology industry.
Is Hemab Therapeutics Holdings' FCF Margin % too high?
Hemab Therapeutics Holdings' current FCF Margin % is 0.00%. Based on the distribution chart, Hemab Therapeutics Holdings ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hemab Therapeutics Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Hemab Therapeutics Holdings' FCF Margin % compare to ZLAB and SLS?
According to the Biotechnology industry distribution chart, Hemab Therapeutics Holdings ranks #999999 out of 953 companies for FCF Margin %. This places Hemab Therapeutics Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hemab Therapeutics Holdings and its competitors. Hemab Therapeutics Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemab Therapeutics Holdings stock overvalued right now?
Hemab Therapeutics Holdings (COAG) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Hemab Therapeutics Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hemab Therapeutics Holdings (COAG), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemab Therapeutics Holdings Business Description

Address 101 Main Street, Suite 1220, Cambridge, MA, USA, 02142
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
11GF Score

Get the complete analysis for COAG

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.52
Price